A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren’s Syndrome

https://www.clinicaltrials.gov/ct2/show/NCT04035668 A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren’s Syndrome (LOUiSSe)

Potential Sjogren’s Therapy LOU064 Shows Promise in Early Lab Studies, Healthy Volunteers

Potential Sjogren’s Therapy LOU064 Shows Promise in Early Lab Studies, Healthy Volunteers Potential Sjogren’s Therapy LOU064 Shows Promise in Early Lab Studies, Healthy Volunteers